Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koiwai Dairy Products is a prominent Japanese dairy company that operates as a joint venture between Kirin Holdings and Koiwai Farm. While primarily known for high-quality milk, yogurt, and cheese, the company is a significant player in the health science sector through its focus on functional foods and fermentation technology. In collaboration with Kirin, Koiwai has been instrumental in the research and commercialization of Lactococcus lactis strain Plasma (LC-Plasma), a postbiotic ingredient designed to support the immune system. This specific strain is the first in Japan to be labeled for immune function support under the Food with Function Claims (FFC) system. The company's business model integrates traditional dairy production with advanced biotechnological research to address consumer health and wellness needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koiwai Dairy Products.